Enorama Pharma AB (publ) (STO: ERMA)

Enorama Pharma AB Revenue

Enorama Pharma AB had revenue of 20.58M SEK in the quarter ending June 30, 2024, with 15.07% growth. This brings the company's revenue in the last twelve months to 80.30M, up 6.88% year-over-year. In the year 2023, Enorama Pharma AB had annual revenue of 75.07M, down -17.52%.

• Revenue (ttm): 80.30M
• Revenue Growth: +6.88%
• P/S Ratio: 33.61
• Revenue / Employee: 1.17M
• Employees: 5
• Market Cap: 290.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	75.07M	-15.95M	-17.52%
Dec 31, 2022	91.02M	7.70M	9.24%
Dec 31, 2021	83.32M	-9.03M	-9.78%
Dec 31, 2020	92.35M	422.00K	0.46%
Dec 31, 2019	91.93M	24.28M	35.90%